LimmaTech Biologics AG
Schlieren, Switzerland
Purpose
To develop a vaccine against Shigella to prevent diarrhea and dysentery, and associated morbidity and mortality, in children under 5-years in low- and middle-income countries.
Division
Global Health
Date
December 2022
Region Served
GLOBAL
Committed amount
$4,638,790
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
48
Grantee location
Schlieren, Switzerland
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.